Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Duhoux, Francois P ^a   Ameye, Geneviève ^a   Lambot, Virginie ^a   Herens, Christian ^b   Lambert, Frédéric ^b   Raynaud, Sophie ^c   Wlodarska, Iwona ^d   Michaux, Lucienne ^d   Roche Lestienne, Catherine ^e   Labis, Elise ^e   Taviaux, Sylvie ^f   Chapiro, Elise ^g   Khac, Florence Nguyen ^g   Struski, Stéphanie ^h   Dobbelstein, Sophie ^h   Dastugue, Nicole ^h   Lippert, Eric ⁱ   Speleman, Frank ^j   van Roy, Nadine ^j   de Weer, An ^j   Rack, Katrina ^k   Talmant, Pascaline ^l   Richebourg, Steven ^l   Mugneret, Francine ^m   Tigaud, Isabelle ⁿ   Mozziconacci, Marie Joëlle ^o   Laibe, Sophy ^o   Nadal, Nathalie ^p   Terré, Christine ^q   Libouton, Jeanne Marie ^a   Decottignies, Anabelle ^r   Vikkula, Miikka ^r   Poirel, Hélène A ^a   more..

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL ARNAUD DE VILLENEUVE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h CHU PURPAN   (France)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j GHENT UNIVERSITY HOSPITAL   (Belgium)

^k INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m DIJON UNIVERSITY HOSPITAL   (France)

ⁿ CENTRE HOSPITALIER LYON SUD   (France)

^o INSTITUT PAOLI CALMETTES   (France)

^p UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^q CENTRE HOSPITALIER DE VERSAILLES   (France)

^r DE DUVE INSTITUTE   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FOLLICULAR LYMPHOMA; GENE CLUSTER; GENE DELETION; GENE LOCUS; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC ASSOCIATION; HMGA2 GENE; HUMAN; HUMAN CELL; KARYOTYPE; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MYELOMA; ONCOGENE; PDRM16 GENE; PRESCHOOL CHILD; RUNX1 GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD DISEASE; CELL LINE; CHROMOSOME 1; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; TELOMERE;

DNA BINDING PROTEIN; PRDM16 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

CELL LINE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERE; TRANSCRIPTION FACTORS;

EID: 80054839180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026311     Document Type: Article

References (53)

1. Gajecka M, Saitta SC, Gentles AJ, Campbell L, Ciprero K, et al. (2010) Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpoints. Am J Med Genet A 152A: 3074-3083.
2. Battaglia A, (2005) Del 1p36 syndrome: a newly emerging clinical entity. Brain Dev 27: 358-361.
3. D'Angelo CS, Gajecka M, Kim CA, Gentles AJ, Glotzbach CD, et al. (2009) Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements. Hum Genet 125: 551-563.
4. Caren H, Fransson S, Ejeskar K, Kogner P, Martinsson T, (2007) Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer 97: 1416-1424.
5. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, et al. (2008) A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6: 735-742.
6. Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, et al. (2011) MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC Cancer 11: 33.
7. Mitelman F, Mertens F, Johansson B, (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15 Spec No pp. 417-474.
8. Lahortiga I, Vazquez I, Belloni E, Roman JP, Gasparini P, et al. (2005) FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome. Hum Genet 116: 476-485.
9. Dave BJ, Hess MM, Pickering DL, Zaleski DH, Pfeifer AL, et al. (1999) Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma. Clin Cancer Res 5: 1401-1409.
10. Hoglund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, et al. (2004) Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 39: 195-204.
11. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, et al. (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A 92: 5520-5524.
12. Dave BJ, Pickering DL, Hess MM, Weisenburger DD, Armitage JO, et al. (1999) Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet Cytogenet 108: 120-126.
13. White PS, Kaufman BA, Marshall HN, Brodeur GM, (1993) Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma. Genes Chromosomes Cancer 7: 102-108.
14. Ellmeier W, Aguzzi A, Kleiner E, Kurzbauer R, Weith A, (1992) Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development. EMBO J 11: 2563-2571.
15. Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, et al. (1994) Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene 9: 2785-2791.
16. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG, (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54: 2869-2872.
17. Oswald C, Stiewe T, (2008) In good times and bad: p73 in cancer. Cell Cycle 7: 1726-1731.
18. Cohen MM Jr, (2009) Perspectives on RUNX genes: an update. Am J Med Genet A 149A: 2629-2646.
19. Ferrand N, Atfi A, Prunier C, (2010) The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor. Cancer Res 70: 8457-8466.
20. Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, et al. (2000) A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96: 3209-3214.
21. Odero MD, Vizmanos JL, Roman JP, Lahortiga I, Panizo C, et al. (2002) A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome. Genes Chromosomes Cancer 35: 11-19.
22. Cheung KJ, Delaney A, Ben-Neriah S, Schein J, Lee T, et al. (2010) High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosomes Cancer 49: 669-681.
23. Shaffer LG, Slovak ML, Campbell LJ, International Standing Committee on Human Cytogenetic Nomenclature (2009) ISCN 2009: an international system for human cytogenetic nomenclature (2009). Basel; Unionville, CT Karger. vi, 138 p., 131 folded leave p.
24. Duhoux FP, De Wilde S, Ameye G, Bahloula K, Medves S, et al. (2010) Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes. Leuk Res.
25. Tilman G, Loriot A, Van Beneden A, Arnoult N, Londono-Vallejo JA, et al. (2009) Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 28: 1682-1693.
26. Kang MA, Kim JT, Kim JH, Kim SY, Kim YH, et al. (2009) Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol 135: 761-769.
27. Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, et al. (2005) Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 19: 245-252.
28. Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, et al. (2005) Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 44: 265-270.
29. Nguyen TT, Ma LN, Slovak ML, Bangs CD, Cherry AM, et al. (2006) Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer 45: 918-932.
30. Rajgopal A, Carr IM, Leek JP, Hodge D, Bell SM, et al. (2003) Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis. Cancer Genet Cytogenet 142: 46-50.
31. Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN, (2007) Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res 13: 4777-4785.
32. Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, et al. (2009) Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 48: 39-54.
33. Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, et al. (2009) Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 113: 137-148.
34. Hofmann WK, Takeuchi S, Xie D, Miller CW, Hoelzer D, et al. (2001) Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes. Leuk Res 25: 855-858.
35. Mori N, Morosetti R, Mizoguchi H, Koeffler HP, (2003) Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol 122: 226-230.
36. Henrich KO, Bauer T, Schulte J, Ehemann V, Deubzer H, et al. (2011) CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells. Cancer Res 71: 3142-3151.
37. Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, et al. (2002) Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas. Int J Cancer 102: 15-19.
38. Stoffel A, Filippa D, Rao PH, (2004) The p73 locus is commonly deleted in non-Hodgkin's lymphomas. Leuk Res 28: 1341-1345.
39. Urashima M, Hoshi Y, Sugimoto Y, Kaihara C, Matsuzaki M, et al. (1996) A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism. Leukemia 10: 1576-1583.
40. Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, et al. (2006) Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107: 742-751.
41. Della Peruta M, Giagulli C, Laudanna C, Scarpa A, Sorio C, (2010) RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones. Mol Cancer 9: 61.
42. Waerner T, Gardellin P, Pfizenmaier K, Weith A, Kraut N, (2001) Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis. Cell Growth Differ 12: 201-210.
43. Okawa ER, Gotoh T, Manne J, Igarashi J, Fujita T, et al. (2008) Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene 27: 803-810.
44. Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, et al. (2010) Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70: 9166-9174.
45. Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, et al. (2011) Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes reflecting tumor and microenvironment. Blood.
46. Theate I, Ameye G, Duhoux FP, Boulet D, Van den Neste E, et al. (2011) Follicular lymphomas without BCL2 rearrangement are heterogeneous concerning the histological grade and genetic features. Ann Oncol 22: iv211-iv212.
47. Katzenberger T, Kalla J, Leich E, Stocklein H, Hartmann E, et al. (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113: 1053-1061.
48. O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, et al. (2009) Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 113: 2298-2301.
49. Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, et al. (1999) Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 25: 123-133.
50. Lestou VS, Ludkovski O, Connors JM, Gascoyne RD, Lam WL, et al. (2003) Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis. Genes Chromosomes Cancer 36: 375-381.
51. Zenz T, Mohr J, Eldering E, Kater AP, Buhler A, et al. (2009) miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 113: 3801-3808.
52. Jain D, Cooper JP, (2010) Telomeric strategies: means to an end. Annu Rev Genet 44: 243-269.
53. Sowa ME, Bennett EJ, Gygi SP, Harper JW, (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389-403.